We are live on ! Find out more
FAF

Fjarde Ap-fonden Portfolio holdings

AUM $20.9B
1-Year Est. Return 36.93%
This Fund
S&P 500
This Quarter Est. Return
+4.89%
1 Year Est. Return
+36.93%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.57B
AUM Growth
+$257M
Cap. Flow
+$90.6M
Cap. Flow %
1.98%
Top 10 Hldgs %
17.55%
Holding
625
New
4
Increased
510
Reduced
87
Closed
12

Sector Composition

Rank Sector Weight
1 Technology 15.65%
2 Healthcare 15.33%
3 Financials 14.65%
4 Communication Services 10.58%
5 Consumer Discretionary 9.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBM icon
26
IBM
IBM
$215B
$34.7M 0.76%
228,205
+5,092
+2% +$773K
DIS icon
27
Walt Disney
DIS
$171B
$34M 0.75%
366,618
+7,532
+2% +$721K
C icon
28
Citigroup
C
$215B
$32.9M 0.72%
696,329
+15,166
+2% +$690K
UNH icon
29
UnitedHealth
UNH
$385B
$31.5M 0.69%
225,029
+5,804
+3% +$813K
AMGN icon
30
Amgen
AMGN
$210B
$29.5M 0.65%
177,098
+4,629
+3% +$783K
ORCL icon
31
Oracle
ORCL
$345B
$28.9M 0.63%
736,242
+10,236
+1% +$417K
BRK.B icon
32
Berkshire Hathaway Class B
BRK.B
$1.1T
$28.7M 0.63%
198,392
+11,095
+6% +$1.62M
MDT icon
33
Medtronic
MDT
$111B
$28.6M 0.63%
331,527
+7,318
+2% +$638K
SLB icon
34
SLB Ltd
SLB
$73.5B
$26.4M 0.58%
335,503
+8,880
+3% +$705K
MMM icon
35
3M
MMM
$92.2B
$25.3M 0.55%
171,836
+5,508
+3% +$822K
GILD icon
36
Gilead Sciences
GILD
$166B
$24.8M 0.54%
313,465
+295
+0.1% +$24K
QCOM icon
37
Qualcomm
QCOM
$170B
$23.9M 0.52%
348,419
+2,759
+0.8% +$168K
MCD icon
38
McDonald's
MCD
$193B
$23.9M 0.52%
206,851
-20
-0% -$2.37K
ABBV icon
39
AbbVie
ABBV
$466B
$23.6M 0.52%
374,778
+15,522
+4% +$1M
MA icon
40
Mastercard
MA
$499B
$23.3M 0.51%
229,423
+3,537
+2% +$339K
CVS icon
41
CVS Health
CVS
$136B
$22.2M 0.49%
249,866
+2,350
+0.9% +$222K
AGN
42
DELISTED
Allergan plc
AGN
$21.6M 0.47%
93,802
+2,623
+3% +$641K
BMY icon
43
Bristol-Myers Squibb
BMY
$130B
$21.2M 0.47%
393,996
+10,402
+3% +$668K
HON icon
44
Honeywell
HON
$76.8B
$19.8M 0.43%
188,524
+3,894
+2% +$407K
RTX icon
45
RTX Corp
RTX
$293B
$19.3M 0.42%
301,996
+8,474
+3% +$562K
CELG
46
DELISTED
Celgene Corp
CELG
$19.1M 0.42%
182,707
+3,144
+2% +$340K
LLY icon
47
Eli Lilly
LLY
$1.08T
$19M 0.42%
236,300
+5,706
+2% +$457K
BA icon
48
Boeing
BA
$171B
$18.9M 0.41%
143,207
-1,493
-1% -$197K
SBUX icon
49
Starbucks
SBUX
$118B
$18.8M 0.41%
347,350
+5,656
+2% +$316K
ACN icon
50
Accenture
ACN
$106B
$18.2M 0.4%
149,356
+4,064
+3% +$463K

Similar funds

Fjarde Ap-fonden's Q3 2016 Portfolio in Review

As of Q3 2016, Fjarde Ap-fonden held 625 positions worth $4.57B, up 6% from $4.31B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Trading was light in Q3 2016: portfolio turnover was 2.6%. Fjarde Ap-fonden opened 4 new positions and exited 12, leaving the 625-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

  • Fjarde Ap-fonden's largest Q3 2016 buy was IHS Markit Ltd. Common Shares: 110,103 shares worth $4.13M.
  • Fjarde Ap-fonden added most to Procter & Gamble in Q3 2016, an estimated $8.7M increase.
  • Fjarde Ap-fonden's biggest Q3 2016 reduction was Danaher, cutting an estimated $3.35M.
  • Fjarde Ap-fonden fully exited EMC CORPORATION in Q3 2016, selling an estimated $12.2M.
  • Fjarde Ap-fonden's ten largest holdings make up 18% of its $4.57B portfolio in Q3 2016.
  • Fjarde Ap-fonden opened 4 new positions and closed 12 in Q3 2016.
  • Fjarde Ap-fonden's portfolio value rose 6% quarter-over-quarter to $4.57B.

Based on Fjarde Ap-fonden's 13F filing for Q3 2016, filed 14 Oct 2016.